Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864221/0/en/Idorsia-publishes-a-Financial-Status-required-for-an-upcoming-bondholder-meeting.html
https://www.globenewswire.com/news-release/2024/04/11/2861225/0/en/Idorsia-takes-steps-to-address-short-term-liquidity-needs.html
https://www.globenewswire.com/news-release/2024/03/31/2854969/0/en/Nxera-Pharma-is-the-New-Name-for-Sosei-Group.html
https://www.prnewswire.com/news-releases/viatris-hosts-rd-event-focusing-on-its-collaboration-with-idorsia-phase-3-assets-selatogrel-and-cenerimod-and-key-elements-of-its-pipeline-302100327.html
https://www.globenewswire.com/news-release/2024/03/22/2850739/0/en/Idorsia-thanks-Guy-Braunstein-for-his-years-of-service-as-he-retires.html
https://www.idorsia.com/media/news/news-archive/media-release-details?id=3195250
https://www.prnewswire.com/news-releases/us-fda-approves-idorsias-once-daily-tryvio-aprocitentan--the-first-and-only-endothelin-receptor-antagonist-for-the-treatment-of-high-blood-pressure-not-adequately-controlled-in-combination-with-other-antihypertensives-302094474.html
https://www.globenewswire.com/news-release/2024/03/18/2847447/0/en/Idorsia-and-Viatris-successfully-close-the-transaction-for-the-global-research-and-development-collaboration.html
https://www.globenewswire.com//news-release/2024/02/28/2836599/0/en/Idorsia-and-Viatris-enter-into-a-significant-global-research-and-development-collaboration.html
https://www.globenewswire.com//news-release/2024/01/10/2806804/0/en/Idorsia-presents-at-the-J-P-Morgan-Healthcare-Conference-Adapting-Idorsia-for-sustainable-value-creation.html